Case Report

Hemolytic Uremic Syndrome Following the Aluminum Phosphide Poisoning: A Case Report

Abstract

Aluminum Phosphide (ALP) is an effective, cheap, and highly toxic pesticide. ALP poisoning can have destructive effects on the human body, such as the heart, lungs, gastrointestinal tract, kidneys, and central nervous system, although all organs can be involved. We describe a 53-year-old Iranian Kurdish man with Hemolytic Uremic Syndrome (HUS) and Acute Kidney Injury (AKI). Supportive treatments such as hemodialysis and plasmapheresis were performed. After 23 days of hospitalization, the patient fully recovered and was discharged. Thrombotic microangiopathy such as HUS should be considered in patients with ALP toxicity that has a genetic defect in complement proteins. Combined use of hemodialysis and plasmapheresis improve outcomes in these patients.

1. Farahani MV, Soroosh D, Marashi SM. Thoughts on the current management of acute aluminum phosphide toxicity and proposals for therapy: An evidence-based review. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2016;20(12):724.
2. Etemadi-Aleagha A, Akhgari M, Iravani FS. Aluminum phosphide poisoning-related deaths in Tehran, Iran, 2006 to 2013. Medicine. 2015;94(38).
3. Sinha N. Aluminium phosphide poisoning. Indian Journal of Medical Specialities. 2018;9(3):167-70.
4. Singh S, Bhalla A. Aluminum phosphide poisoning. Journal of Mahatma Gandhi Institute of Medical Sciences. 2015;20(1):15.
5. Saif Q, Ruhi K, Aparna S. Aluminium phosphide induced acute kidney injury. The Egyptian Journal of Internal Medicine. 2015;27(3):115-7.
6. Mehrpour O, Jafarzadeh M, Abdollahi M. A systematic review of aluminum phosphide poisoning. Arhiv za higijenu rada i toksikologiju. 2012;63(1):61.
7. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clinical Journal of the American Society of Nephrology. 2010;5(10):1844-59.
8. Obrig TG, Karpman D. Shiga toxin pathogenesis: kidney complications and renal failure. Ricin and Shiga Toxins. 2011:105-36.
9. Shafahi A, Mostafazadeh B, Dadpour B. Inhalational toxicity of aluminum phosphide as an ongoing concern; a report of two cases. Archives of academic emergency medicine. 2019;7(1).
10. Adamski J. Thrombotic microangiopathy and indications for therapeutic plasma exchange. Hematology 2014, the American Society of Hematology Education Program Book. 2014;2014(1):444-9.
11. Grisaru S. Management of hemolytic-uremic syndrome in children. International journal of nephrology and renovascular disease. 2014;7:231.
12. Noris M, Remuzzi G. Hemolytic uremic syndrome. Journal of the American Society of Nephrology. 2005;16(4):1035-50.
13. Zafrani L, Mariotte E, Darmon M, Canet E, Merceron S, Boutboul D, et al. Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS 13 activity. Journal of Thrombosis and Haemostasis. 2015;13(3):380-9.
Files
IssueVol 61 No 10 (2023) QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/acta.v61i10.15664
Keywords
Aluminum phosphide poisoning Hemolytic uremic syndrome Acute kidney injury
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Asadzadeh R, Mozafari A, Taghinezhad F, Pourrezagholi F, Khalighi Z. Hemolytic Uremic Syndrome Following the Aluminum Phosphide Poisoning: A Case Report. Acta Med Iran. 2024;61(10):632-634.